KIT
Drug: Sorafenib
Cancer code: LAML
Cancer type: acute_myeloid_leukaemia
Drug treatment table
| Cell line ID |
Cell line name |
Mutation in substructure |
IC50(uM) |
| SIDM01005 | KASUMI-1 | A_loop (822) | 40.2854 |
| SIDM00951 | CTV-1 | None | 8.663 |
| SIDM00829 | HL-60 | None | 2.9125 |
| SIDM00594 | HEL | None | 5.4249 |
| SIDM00785 | KG-1 | None | 1.6928 |
| SIDM01019 | KMOE-2 | None | 1.7077 |
| SIDM00441 | ML-2 | None | 3.7947 |
| SIDM01023 | MONO-MAC-6 | None | 0.0314 |
| SIDM00580 | NOMO-1 | None | 14.1514 |
| SIDM00363 | P31-FUJ | None | 15.4621 |
| SIDM00396 | SIG-M5 | None | 1.9362 |
| SIDM01172 | THP-1 | None | 13.4973 |
| SIDM00467 | QIMR-WIL | None | 2.0355 |
| SIDM00959 | CMK | None | 6.6144 |
| SIDM00917 | CESS | None | 3.5275 |
| SIDM00446 | OCI-AML2 | None | 0.9885 |
| SIDM00462 | OCI-AML3 | None | 6.5993 |
| SIDM00428 | NB4 | None | 2.5852 |
| SIDM00338 | ME-1 | None | 6.4808 |
| SIDM00461 | OCI-AML5 | None | 0.9023 |
| SIDM00458 | OCI-M1 | None | 3.0413 |
| SIDM00450 | PL-21 | None | 7.8029 |
| SIDM00951 | CTV-1 | None | 5.3571 |
| SIDM00829 | HL-60 | None | 1.9089 |
| SIDM01057 | GDM-1 | None | 0.1424 |
| SIDM00785 | KG-1 | None | 2.9041 |
| SIDM01019 | KMOE-2 | None | 1.8214 |
| SIDM00441 | ML-2 | None | 4.9408 |
| SIDM01023 | MONO-MAC-6 | None | 0.0105 |
| SIDM00576 | NKM-1 | None | 0.1242 |
| SIDM00580 | NOMO-1 | None | 8.8966 |
| SIDM00363 | P31-FUJ | None | 8.5633 |
| SIDM00917 | CESS | None | 4.1243 |
| SIDM00446 | OCI-AML2 | None | 2.0997 |
| SIDM00462 | OCI-AML3 | None | 2.9952 |
| SIDM00338 | ME-1 | None | 6.2637 |
| SIDM00437 | MOLM-13 | None | 0.0041 |
| SIDM00458 | OCI-M1 | None | 5.2168 |